Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.

Become a member

link Linked'In (5)

Join us to kick off 2023 together and stay connected!

Don't miss the keynote "Wellbeing is key for business succes" by Gert Braeken author of the book 'Het burn-outvaccin'.

Healixia events

There are no meetings published at the moment. Please check back later!

News

  1. January 27, 2023

    End of the validation procedure for SARS-CoV-2 antigen self-tests

    The validation procedure for SARS-CoV-2 antigen self-tests with a CE-marking ceased to apply since 23 January 2023. The associated list of recommended SARS-CoV-2 antigen self-tests with a CE-marking is therefore no longer available.

    Source: FAMHP

    Read more

  2. January 27, 2023

    PRAC January 2023 - recommendations for Janus kinase (JAK) inhibitors and information about Zolgensma

    Alignment of dose recommendations for Janus kinase (JAK) inhibitors in patients with certain risk factors
    EMA’s safety committee (PRAC) has further reviewed measures to minimise the risk of serious side effects associated with Janus kinase (JAK) inhibitors used to treat several chronic inflammatory disorders.

    Source: FAMHP

    Read more

  3. January 17, 2023

    IFAPP Today newsletter - January 2023

    Source: IFAPP

    Please find here the link to the IFAPP TODAY newsletter of January 2023.

    Read more

We thank our partners for their support:

AxTalis_reg access medical_scherm_transparent Brookwood Global-website QbD Group Logo_blue Janssen 440x320 nieuwsbrief